Luis Ambert, MD
Urology · Rio Piedras, PRNPI 1295794014
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $48,000 of the $64,499 with a category attached, or 74.4%. Verity Pharmaceuticals Inc. accounts for 93.0% of it on its own, with 20 other manufacturers making up the rest. Among urology clinicians in PR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 103 payments — averaging $626.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Verity Pharmaceuticals Inc.$60K
- Boston Scientific$1K
- Medtronic$690
- Travere Therapeutics, Inc.$366
- BD$358
- Johnson & Johnson$321
- plus $2K from 15 others
What the payments were for
- Consulting fees$12,00019%
- Speaking & faculty fees$48,00074%
- Food & beverage$4,3767%
- Education$1230%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Verity Pharmaceuticals Inc. | 10 | $60,000 |
| Boston Scientific | 15 | $1,165 |
| Medtronic | 38 | $690 |
| Travere Therapeutics, Inc. | 4 | $366 |
| BD | 7 | $358 |
| Johnson & Johnson(2 entities) | 6 | $321 |
| Merck | 2 | $224 |
| Teleflex LLC | 2 | $224 |
| Neotract Inc. | 2 | $199 |
| Ferring Pharmaceuticals Inc. | 4 | $188 |
| Progenics Pharmaceuticals, Inc. | 1 | $124 |
| Axonics, Inc. | 1 | $121 |
| Urogen Pharma, Inc. | 1 | $114 |
| Olympus Latin America, Inc. | 1 | $100 |
| Bard Peripheral Vascular, Inc. | 1 | $85 |
| Tolmar Pharmaceuticals, Inc. | 1 | $64 |
| AbbVie | 2 | $50 |
| PBG Puerto Rico LLC | 2 | $49 |
| Pfizer Pharmaceuticals LLC | 1 | $24 |
| Tolmar, Inc. | 1 | $19 |
| Pharmaand GmbH | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELSTAR$60,000
- GENERAL BPH$256
- INTERSTIM$251
- (815) Thiola$249
- UroLift$240
- KEYTRUDA$224
- AMS 700 CXR RTE KIT$139
- Proxis Ureteral Access Sheath$130
- ADSTILADRIN$128
- Erleada$125
- PYLARIFY$124
- Axonics r-SNM System$121
- JELMYTO$114
- REZUM$103
- Olympus Cysto-Resection$100
How this compares
$64,499 in reported general payments places this provider in the 95th percentile of 122 urology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 356 | $170,148 |
| Bethanechol Chloride | 1,725 | $140,126 |
| Tolterodine Tartrate ErTolterodine Tartrate | 321 | $15,910 |
| Tamsulosin Hcl | 1,878 | $15,391 |
| Oxybutynin Chloride ErOxybutynin Chloride | 927 | $13,523 |
| Methenamine Hippurate | 379 | $12,800 |
| Ciprofloxacin Hcl | 763 | $5,599 |
| Bicalutamide | 195 | $5,546 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 458 | $5,366 |
| Tadalafil | 75 | $4,064 |
| Sildenafil Citrate | 127 | $2,321 |
| Doxazosin Mesylate | 144 | $2,030 |
| Trospium Chloride ErTrospium Chloride | 18 | $1,954 |
| Testosterone Cypionate | 27 | $1,500 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 48 | $1,219 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieSynthroid | $50 | $1,06620 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 122 urology providers in Puerto Rico.
Other urology in Rio Piedras
- Jorge Crespo CarrilloRio Piedras$62K
- Claudio Bernaschina BobadillaPonce$132K
- Mariela Martinez-RiveraPonce$105K
- Freddy Mendez TorresCayey$95K
- Ronald Cadillo ChavezBayamon$61K
- Andres Perez RomanSan Juan$58K
- Rafael Bouet BlasiniSan Juan$55K
- Antonio Yulian ValentinCaguas$48K
- Alberto Ramirez LopezDorado$47K
- Jose Saavedra-BelaundeSan Juan$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.